| Literature DB >> 31251755 |
Cameron Meaney1, Marek Stastna1, Mehran Kardar2, Mohammad Kohandel1.
Abstract
Glioblastomas are the most common primary brain tumours. They are known for their highly aggressive growth and invasion, leading to short survival times. Treatments for glioblastomas commonly involve a combination of surgical intervention, chemotherapy, and external beam radiation therapy (XRT). Previous works have not only successfully modelled the natural growth of glioblastomas in vivo, but also show potential for the prediction of response to radiation prior to treatment. This suggests that the efficacy of XRT can be optimized before treatment in order to yield longer survival times. However, while current efforts focus on optimal scheduling of radiotherapy treatment, they do not include a similarly sophisticated spatial optimization. In an effort to improve XRT, we present a method for the spatial optimization of radiation profiles. We expand upon previous results in the general problem and examine the more physically reasonable cases of 1-step and 2-step radiation profiles during the first and second XRT fractions. The results show that by including spatial optimization in XRT, while retaining a constant prescribed total dose amount, we are able to increase the total cell kill from the clinically-applied uniform case.Entities:
Mesh:
Year: 2019 PMID: 31251755 PMCID: PMC6599149 DOI: 10.1371/journal.pone.0217354
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Model parameters.
| Parameter | Symbol | Value (Unit) | Reference |
|---|---|---|---|
| Initial Total Cell Number | 107 (cells) | This Work | |
| Tumour Cell Diffusivity | 0.32 (mm2/day) | [ | |
| Tumour Cell Proliferation Rate | 0.35 (1/day) | [ | |
| Linear-Quadratic Parameter | 0.08 (1/Gy) | Average of values from [ | |
| Dose Rate during Radiation |
| 5 (Gy/fraction) | Chosen within range from [ |
| Radiation Effect Parameter | 60 (1/day) | Estimated from | |
| Dose Limiting Parameter | C | 2.5 (Gy) | This Work |
Model parameters used in the various calculations and simulations throughout the paper. Those with the given reference of ‘This Work’ were selected within a biologically reasonable range from various sources as an example for calculations.
One fraction & one radial step.
| 1 | 1.59e6 |
| 2.50 | 3.54e6 |
| 2 | 3.98e5 |
| 2.50 | 5.36e6 |
| 3 | 1.78e5 | 3.71 | 1.82 | 7.16e6 |
| 4 | 1.04e5 | 4.28 | 1.36 | 8.01e6 |
| 5 | 7.36e4 | 4.79 | 1.09 | 8.43e6 |
Optimal one-step profile for one fraction of radiation with exponential growth and death.n0 and σ are the magnitude and standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r1 and f1 are the radius and strength of the step in the cytotoxic radiation profile. N(t + dt) is the final tumour cell number at the end of radiation.
One fraction & two radial steps.
| 1 | 3.06 | 3.27 | 2.50 | 1.18 | 3.54e6 |
| 2 | 2.81 | 3.47 | 2.50 | 1.27 | 5.30e6 |
| 3 | 2.81 | 3.98 | 2.10 | 1.06 | 7.10e6 |
| 4 | 3.26 | 4.61 | 1.57 | 0.78 | 7.98e6 |
| 5 | 3.64 | 5.15 | 1.26 | 0.64 | 8.41e6 |
Optimal two-step profile for one fraction of radiation with exponential growth and death. σ is the standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r1, r2, f1 and f2 are the two radii and strengths of the steps in the cytotoxic radiation profile. N(t + dt) is the final tumour cell number at the end of radiation.
Two two-step fractions, separately constrained.
| 1 | 3.06 | 3.27 | 2.50 | 1.18 | 2.93 | 3.36 | 2.50 | 1.30 | 1.29e6 |
| 2 | 2.81 | 3.47 | 2.50 | 1.27 | 1.97 | 4.04 | 2.42 | 1.26 | 3.41e6 |
| 3 | 2.81 | 3.98 | 2.10 | 1.06 | 4.61 | 5.03 | 1.07 | 0.57 | 5.59e6 |
| 4 | 3.26 | 4.61 | 1.57 | 0.78 | 5.36 | 5.84 | 0.80 | 0.39 | 6.80e6 |
| 5 | 3.64 | 5.15 | 1.26 | 0.64 | 5.98 | 6.54 | 0.64 | 0.31 | 7.52e6 |
Optimal two-step profile for two separately constrained fractions of radiation with exponential growth and death. σ is the standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r11, r21, r12, r22, f11, f21, f12 and f22 are the radii and strengths of the steps in the cytotoxic radiation profiles. N(t + dt) is the final tumour cell number at the end of radiation.
Two two-step fractions, mutually constrained.
| 1 | 3.06 | 3.27 | 2.50 | 1.18 | 2.93 | 3.36 | 2.50 | 1.30 | 1.29e6 |
| 2 | 2.81 | 3.47 | 2.50 | 1.27 | 1.97 | 4.04 | 2.42 | 1.26 | 3.41e6 |
| 3 | 3.55 | 4.92 | 1.63 | 0.82 | 2.56 | 4.31 | 1.61 | 0.78 | 5.59e6 |
| 4 | 4.20 | 5.74 | 1.21 | 0.61 | 2.97 | 4.92 | 1.22 | 0.55 | 6.79e6 |
| 5 | 4.63 | 6.34 | 1.02 | 0.50 | 3.28 | 5.52 | 0.96 | 0.43 | 7.42e6 |
Optimal two-step profile for two mutually constrained fractions of radiation with exponential growth and death. σ is the standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r11, r21, r12, r22, f11, f21, f12 and f22 are the radii and strengths of the steps in the cytotoxic radiation profiles. N(t + dt) is the final tumour cell number at the end of radiation.
Variation of flux over two fractions.
| 1st Fraction | 2nd Fraction | |
|---|---|---|
| 1 | 25.00 | 25.00 |
| 2 | 25.00 | 25.00 |
| 3 | 30.08 | 19.92 |
| 4 | 30.77 | 19.23 |
| 5 | 31.27 | 18.73 |
Distribution of radiation flux over two radiation fractions based on standard deviation of initial tumour cell density. The ‘1st Fraction’ number represents the amount of dose (out of 50) that is allocated to the 1st radiation fraction and the ‘2nd fraction’ the amount allocated to the 2nd radiation fraction.
Fitted parameters as in Eq (31).
| 1 | 2.0697e6 | 0.4237 | 0.04007 |
| 3 | 1.0978e6 | -0.3069 | -0.004395 |
| 5 | 1553387 | -0.02081 | -0.01505 |
Fitting parameters for initial density generated by simulation with logistic growth. Parameters correspond to those in Eq (31).
One fraction & two radial steps for logistic growth.
| 1 | 3.89 | 5.23 | 1.16 | 0.61 |
| 3 | 6.73 | 10.00 | 0.34 | 0.17 |
| 5 | 5.80 | 10.00 | 0.26 | 0.24 |
Optimal one-step profile for one fraction of radiation with logistic growth and exponential death. σ is the standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r1, r2, f1, and f2 are the radii and strengths of the steps in the cytotoxic radiation profiles. N(t + dt) is the final tumour cell number at the end of radiation.
Two two-step fractions, each separately constrained for logistic growth.
| 1 | 3.89 | 5.23 | 1.16 | 0.61 | 5.92 | 6.37 | 0.66 | 0.33 |
| 3 | 6.73 | 10.00 | 0.34 | 0.17 | 3.98 | 10.00 | 0.31 | 0.24 |
| 5 | 5.81 | 10.00 | 0.26 | 0.24 | 8.47 | 10.00 | 0.25 | 0.25 |
Optimal one-step profile for one fraction of radiation with logistic growth and exponential death. σ is the standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r11, r21, r12, r22, f11, f21, f12 and f22 are the radii and strengths of the steps in the cytotoxic radiation profiles. N(t + dt) is the final tumour cell number at the end of radiation.
One two-step fraction, logistic death.
| 1 | 4.3933 | 5.7914 | 0.0000 | 1.7557 |
| 3 | 9.4731 | 9.9886 | 0.0005 | 2.4875 |
| 5 | 9.4774 | 9.9906 | 0.0009 | 2.4940 |
Optimal two-step profile for one fraction of radiation with logistic growth and death. σ is the standard deviation of the initial Gaussian tumour cell density, which starts with 107 total cells. r1, r2, f1, and f2 are the radii and strengths of the steps in the cytotoxic radiation profiles. N(t + dt) is the final tumour cell number at the end of radiation.
Summary of discrete optimization cases.
| Subsection | Dose Profile | # Fractions | Dose Constraint | Growth | Death | Optimization Method |
|---|---|---|---|---|---|---|
| D1 | One-Step | 1 | Exponential | Exponential | Lagrange Multiplier | |
| D2 | Two-Step | 1 | Exponential | Exponential | Monte Carlo | |
| D3 | Two-Step | 2 | Exponential | Exponential | Monte Carlo | |
| D4 | Two-Step | 2 | Exponential | Exponential | Monte Carlo | |
| D5 | Two-Step | 1 | Logistic | Exponential | Monte Carlo | |
| D6 | Two-Step | 1 | Logistic | Logistic | Monte Carlo |
A summary of the discrete optimization cases undertaken herein.